Breaking News

Modernizing Biopharmaceutical Sampling

July 31, 2014

Funded so far by Pfizer and Lilly, Bend Research is beta testing the Modular Automated Sampling Technology platform, that would bring process analytical technology (PAT) to biopharmaceutical development and manufacturing

Bend Research and pharmaceutical company partners are currently beta testing MAST, a modular automated sampling technology platform designed to allow for hands-off and contamination-free sampling from up to 8 bioreactors at a time.  The platform has also been designed to enable at-line analysis, automated scheduling and other benefits.  For more information, click here. 
blog comments powered by Disqus
  • The Role of Value in Drug Pricing

    The Role of Value in Drug Pricing

    Keren Shani, Ryan Million, Trinity Partners ||October 11, 2016
    Exploring the trend of using frameworks and models to evaluate the value of a drug

  • CRO-Sponsor Partnerships

    CRO-Sponsor Partnerships

    Craig Morgan, Brand Development Director, goBalto Inc.||October 11, 2016
    10 tips for enabling better CRO and sponsor collaborations

  • The Human Parts of Mouse Models

    The Human Parts of Mouse Models

    Julia Schueler, Head of in vivo Operations, Oncotest, a Charles River company ||October 11, 2016
    The PDX model system has come back into focus